NO attenuates insulin signaling and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B-mediated mechanism

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 7, 2002, Pages 1086-1092

  Sreejayan, Nair ^a   Lin, Yi ^a   Hassid, Aviv ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Atherosclerosis; Cell signaling; Growth factors; Signal transduction; Type 2 diabetes

Indexed keywords

ADENOVIRUS VECTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR SUBUNIT;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; INSULIN METABOLISM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; AORTA, THORACIC; BUTADIENES; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MUTATION; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRILES; PENICILLAMINE; PHOSPHOTYROSINE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0036061898     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000020550.65963.E9     Document Type: Article

References (39)

1. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
2. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: Lack of direct growth-promoting effects of high glucose levels
3. Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats
4. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration
5. ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity
6. Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin El
7. Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells
8. Increased SMC proliferation after endothelial injury in hyperinsulinemic obese Zucker rats
9. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
10. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
11. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity
12. NO alters cell shape and motility in aortic smooth muscle cells via protein tyrosine phosphatase 1B activation
13. L-arginine inhibits balloon catheter-induced intimal hyperplasia
14. Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene
15. Cultured aortic smooth muscle cells from newborn and adult rats show distinct cytoskeletal features
16. Nitric oxide availability in diabetes mellitus
17. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway
18. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling
19. Down-regulation of insulin signaling by protein tyrosine phosphatase (PTP) 1B is mediated by an N-terminal binding region
20. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor: A brute force approach based on "substrate-trapping" mutants
21. NO increases protein tyrosine phosphatase activity in smooth muscle cells: Relationship to antimitogenesis
22. Cloning of a cDNA for a major human protein-tyrosine-phosphatase
23. Murine protein tyrosine phosphatase-PEST, a stable cytosolic protein tyrosine phosphatase
24. A simple method for the rapid generation of recombinant adenovirus vectors
25. Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: Relationship to microfilament dissociation and altered cell morphology
26. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells
27. Role of PTP-1B in aortic smooth muscle cell motility and tyrosine phosphorylation of focal adhesion proteins
28. Signalling through the insulin receptor
29. PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates
30. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
31. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension
32. Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria: Efficient synthesis of active protein kinases
33. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
34. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
35. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase
36. Protein tyrosine phosphatase 1B interacts with the activated insulin receptor
37. Protein tyrosine phosphatase 1B negatively regulates integrin signaling
38. Cloning of the mouse insulin receptor substrate-1 (IRS-1) gene and complete sequence of mouse IRS-1
39. Requirement of protein tyrosine phosphatase SHP2 for NO-stimulated vascular smooth muscle cell motility